|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/19 | |
| A61K 38/36 |
| (11) | Patento numeris | 1703899 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 04804925.8 |
| Europos patento paraiškos padavimo data | 2004-12-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-09-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2011-05-04 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2004/053587 |
| Data | 2004-12-17 |
| (87) | Numeris | WO 2005/058283 |
| Data | 2005-06-30 |
| (30) | Numeris | Data | Šalis |
| 200301901 | 2003-12-19 | DK |
| (72) |
HANSEN, Birthe, Lykkegaard, DK
JENSEN, Michael, Bech, DK
KORNFELT, Troels, DK
|
| (73) |
Novo Nordisk Health Care AG,
Andreasstrasse 15, 8050 Zürich,
CH
|
| (54) | STABILISED COMPOSITIONS OF FACTOR VII POLYPEPTIDES |
| STABILISED COMPOSITIONS OF FACTOR VII POLYPEPTIDES |